BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36867420)

  • 1. One-Year Adverse Outcomes Among US Adults With Post-COVID-19 Condition vs Those Without COVID-19 in a Large Commercial Insurance Database.
    DeVries A; Shambhu S; Sloop S; Overhage JM
    JAMA Health Forum; 2023 Mar; 4(3):e230010. PubMed ID: 36867420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
    Xie Y; Choi T; Al-Aly Z
    JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Characteristics Associated With Post-COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults.
    Selvakumar J; Havdal LB; Drevvatne M; Brodwall EM; Lund Berven L; Stiansen-Sonerud T; Einvik G; Leegaard TM; Tjade T; Michelsen AE; Mollnes TE; Lund-Johansen F; Holmøy T; Zetterberg H; Blennow K; Sandler CX; Cvejic E; Lloyd AR; Wyller VBB
    JAMA Netw Open; 2023 Mar; 6(3):e235763. PubMed ID: 36995712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection.
    Tartof SY; Malden DE; Liu IA; Sy LS; Lewin BJ; Williams JTB; Hambidge SJ; Alpern JD; Daley MF; Nelson JC; McClure D; Zerbo O; Henninger ML; Fuller C; Weintraub E; Saydah S; Qian L
    JAMA Netw Open; 2022 Aug; 5(8):e2225657. PubMed ID: 35960522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidimensional Sleep Health Prior to SARS-CoV-2 Infection and Risk of Post-COVID-19 Condition.
    Wang S; Huang T; Weisskopf MG; Kang JH; Chavarro JE; Roberts AL
    JAMA Netw Open; 2023 May; 6(5):e2315885. PubMed ID: 37252741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to Healthy Lifestyle Prior to Infection and Risk of Post-COVID-19 Condition.
    Wang S; Li Y; Yue Y; Yuan C; Kang JH; Chavarro JE; Bhupathiraju SN; Roberts AL
    JAMA Intern Med; 2023 Mar; 183(3):232-241. PubMed ID: 36745445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
    Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and Postacute COVID-19 Outcomes Among Immunologically Naive Adults During Delta vs Omicron Waves.
    Doll MK; Waghmare A; Heit A; Levenson Shakoor B; Kimball LE; Ozbek N; Blazevic RL; Mose L; Boonyaratanakornkit J; Stevens-Ayers TL; Cornell K; Sheppard BD; Hampson E; Sharmin F; Goodwin B; Dan JM; Archie T; O'Connor T; Heckerman D; Schmitz F; Boeckh M; Crotty S
    JAMA Netw Open; 2023 Feb; 6(2):e231181. PubMed ID: 36853602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.
    Richard SA; Pollett SD; Fries AC; Berjohn CM; Maves RC; Lalani T; Smith AG; Mody RM; Ganesan A; Colombo RE; Lindholm DA; Morris MJ; Huprikar N; Colombo CJ; Madar C; Jones M; Larson DT; Bazan SE; Mende K; Saunders D; Livezey J; Lanteri CA; Scher AI; Byrne C; Rusiecki J; Ewers E; Epsi NJ; Rozman JS; English C; Simons MP; Tribble DR; Agan BK; Burgess TH;
    JAMA Netw Open; 2023 Jan; 6(1):e2251360. PubMed ID: 36652247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived Cognitive Deficits in Patients With Symptomatic SARS-CoV-2 and Their Association With Post-COVID-19 Condition.
    Liu TC; Yoo SM; Sim MS; Motwani Y; Viswanathan N; Wenger NS
    JAMA Netw Open; 2023 May; 6(5):e2311974. PubMed ID: 37145596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric Symptoms, Treatment Uptake, and Barriers to Mental Health Care Among US Adults With Post-COVID-19 Condition.
    Naik H; Tran KC; Staples JA; Perlis RH; Levin A
    JAMA Netw Open; 2024 Apr; 7(4):e248481. PubMed ID: 38662370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-COVID-19 Condition in Children 6 and 12 Months After Infection.
    Dun-Dery F; Xie J; Winston K; Burstein B; Gravel J; Emsley J; Sabhaney V; Zemek R; Berthelot S; Beer D; Kam A; Freire G; Mater A; Porter R; Poonai N; Moffatt A; Dixon A; Salvadori MI; Freedman SB;
    JAMA Netw Open; 2023 Dec; 6(12):e2349613. PubMed ID: 38153737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Care Access and Affordability Among US Adults Aged 18 to 64 Years With Self-reported Post-COVID-19 Condition.
    Karpman M; Zuckerman S; Morriss S
    JAMA Netw Open; 2023 Apr; 6(4):e237455. PubMed ID: 37036705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Initial SARS-CoV-2 Test Positivity With Patient-Reported Well-being 3 Months After a Symptomatic Illness.
    Wisk LE; Gottlieb MA; Spatz ES; Yu H; Wang RC; Slovis BH; Saydah S; Plumb ID; O'Laughlin KN; Montoy JCC; McDonald SA; Lin Z; Lin JS; Koo K; Idris AH; Huebinger RM; Hill MJ; Gentile NL; Chang AM; Anderson J; Hota B; Venkatesh AK; Weinstein RA; Elmore JG; Nichol G;
    JAMA Netw Open; 2022 Dec; 5(12):e2244486. PubMed ID: 36454572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study.
    Cohen K; Ren S; Heath K; Dasmariñas MC; Jubilo KG; Guo Y; Lipsitch M; Daugherty SE
    BMJ; 2022 Feb; 376():e068414. PubMed ID: 35140117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Limitations and Exercise Intolerance in Patients With Post-COVID Condition: A Randomized Crossover Clinical Trial.
    Tryfonos A; Pourhamidi K; Jörnåker G; Engvall M; Eriksson L; Elhallos S; Asplund N; Mandic M; Sundblad P; Sepic A; Rullman E; Hyllienmark L; Rundqvist H; Lundberg TR; Gustafsson T
    JAMA Netw Open; 2024 Apr; 7(4):e244386. PubMed ID: 38573638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.